Medicare Enrolled

Dr. Gerardo Trillo, M.D.

Medical Oncology · Frisco, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4461 COIT RD, Frisco, TX 75035
9729871975
In practice since 2006 (19 years)
NPI: 1770521387 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Trillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trillo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Trillo

Dr. Gerardo Trillo is a medical oncology in Frisco, TX, with 19 years in practice. Based on federal Medicare data, Dr. Trillo performed 119,293 Medicare services across 3,579 unique beneficiaries.

Between the years covered by Open Payments, Dr. Trillo received a total of $2,801 from 45 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Trillo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 6% volume in TX$ $2,801 industry payments

Medicare Practice Summary

Medicare Utilization ↗
119,293
Medicare services
Top 6% in TX for medical oncology
3,579
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,279 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)28,560$0$5
Iron sucrose injection (Venofer)20,500$0$2
Filgrastim injection (Nivestym) for white blood cells18,480$0$2
Anti-nausea injection (fosaprepitant)13,950$0$5
Darbepoetin injection (Aranesp) for anemia13,435$2$20
Immune globulin infusion (Octagam)9,060$33$234
Dexamethasone injection (steroid)3,632$0$1
Blood draw (venipuncture)1,481$8$20
Complete blood count (CBC) with differential1,260$8$36
Injection, granisetron hydrochloride, 100 mcg1,210$0$24
Anti-nausea injection (Aloxi/palonosetron)1,060$1$114
Comprehensive metabolic blood panel638$10$64
Injection of additional new drug or substance into vein610$12$108
Office visit, established patient (30-39 min)537$90$368
Office visit, established patient (20-29 min)413$63$250
Administration of chemotherapy into vein, 1 hour or less370$97$707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less352$48$313
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour331$16$100
Ferritin level test (iron stores)315$13$60
Iron level test315$6$27
Iron binding capacity test315$8$35
Drug injection, under skin or into muscle296$11$96
Administration of chemotherapy into vein, each additional hour224$21$161
Microscopic examination for white blood cells with manual cell count214$4$22
Complete blood count (CBC), automated214$6$34
Injection, diphenhydramine hcl, up to 50 mg170$1$7
Injection, zoledronic acid, 1 mg157$7$431
New patient office visit, complex (60-74 min)135$148$709
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less127$21$157
Administration of additional new drug or substance into vein, 1 hour or less113$49$344
Administration of additional new drug or substance into vein using push technique86$41$289
Nuclear medicine study from skull base to mid-thigh with ct scan82$1,102$4,802
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries79$90$657
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle77$25$145
Office visit, established patient, complex (40-54 min)69$114$496
Drawing of blood for a medical problem64$66$264
Lactate dehydrogenase (enzyme) level60$6$31
PSA test (prostate cancer screening)53$18$94
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-353$20$128
Red blood count automated, with additional calculations45$5$26
Hospital follow-up visit, high complexity42$91$357
Infusion, normal saline solution , 1000 cc38$2$19
Carcinoembryonic antigen (cea) protein level28$19$99
Stool analysis for blood to screen for colon tumors26$4$24
Initial hospital admission, high complexity17$133$694
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.2% high complexity
62.2% medium
5.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,801
Total received (2018-2024)
Avg $400/year across 7 years
Bottom 45% in TX for medical oncology
45
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,478 (88.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$323 (11.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,250
2023
$1,020
2022
$362
2021
$26
2020
$18
2019
$39
2018
$87

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$265
Astellas Pharma US Inc
$262
Novartis Pharmaceuticals Corporation
$198
Gilead Sciences, Inc.
$168
Daiichi Sankyo Inc.
$163
E.R. Squibb & Sons, L.L.C.
$163
Celgene Corporation
$161
PharmaEssentia USA Corporation
$111
Merck Sharp & Dohme LLC
$110
AstraZeneca Pharmaceuticals LP
$110
Janssen Biotech, Inc.
$91
Seagen Inc.
$58
Pharming Healthcare, Inc.
$58
GENZYME CORPORATION
$48
Sirtex Medical Inc
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
ABBVIE INC.
$43
Tempus AI, Inc
$43
ARRAY BIOPHARMA INC
$42
BeiGene USA, Inc.
$39
AVEO Pharmaceuticals, Inc.
$37
Janssen Pharmaceuticals, Inc
$33
Aveo Pharmaceuticals, Inc.
$30
Deciphera Pharmaceuticals Inc.
$30
Fennec Pharmaceuticals, Inc.
$28
Jazz Pharmaceuticals Inc.
$28
GE HealthCare
$28
Rigel Pharmaceuticals, Inc.
$25
SOBI, INC
$25
Acrotech Biopharma LLC
$24
Alnylam Pharmaceuticals Inc.
$23
CTI BioPharma Corp.
$23
Puma Biotechnology, Inc.
$23
Genentech USA, Inc.
$23
Karyopharm Therapeutics Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Eisai Inc.
$20
Merck Sharp & Dohme Corporation
$20
Mirati Therapeutics, Inc.
$20
Incyte Corporation
$19
Blueprint Medicines Corporation
$19
ADC Therapeutics America, Inc.
$18
GlaxoSmithKline, LLC.
$16
Epizyme, Inc.,
$13
Pharmacyclics LLC, An AbbVie Company
$13
Top 3 companies account for 25.9% of total payments
Associated products mentioned in payments ›
AYVAKIT · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · CALQUENCE · DARZALEX · Doptelet · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · Enhertu · FOTIVDA · IBRANCE · IMFINZI · INJECTAFER · INLYTA · KEYTRUDA · KISQALI · KRAZATI · Lenvima · MEKINIST · MONJUVI · Nubeqa · OPDIVO · OPDUALAG · OXBRYTA · OXLUMO · PADCEV · PLUVICTO · Padcev · Pedmark · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · SIR-Spheres Microspheres · SUTENT · TAZVERIK · TUKYSA · Trodelvy · VONVENDI · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a medical oncology in Frisco?
Compare medical oncologys in the Frisco area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
48
Per 100K population
4.3
County median income
$117,588
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER - CENTENNIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Trillo is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Trillo experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Trillo performed 28,560 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trillo receive payments from pharmaceutical companies?
Yes. Dr. Trillo received a total of $2,801 from 45 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trillo's costs compare to other medical oncologys in Frisco?
Dr. Trillo's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →